Frutos-López, ManuelPedrote, AlonsoAcosta-Martínez, JuanArana-Rueda, Eduardo2023-02-082023-02-082020-04-23http://hdl.handle.net/10668/15435Antiarrhythmic drugs are often the last resort for recurrent ventricular tachycardia refractory to catheter ablation in implantable cardioverter-defibrillator carriers. Amiodarone, alone or combined with mexiletine, is usually but not always highly effective, and its use is usually limited by systemic adverse effects. We present the case of a 62 years old man with recurrent ICD shocks due to a VT refractory to an endo-epicardial hybrid ablation. Starting of dronedarone plus mexiletine combination showed an excellent result.enAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/Ablação por cateterAntiarrhythmic drugsArritmias ventricularesCatheter ablationDronedaronaDronedaroneFármacos anti-arrítmicosMexiletinaMexiletineVentricular arrhythmiasAmiodaroneAnti-Arrhythmia AgentsCatheter AblationDefibrillators, ImplantableDronedaroneDrug Therapy, CombinationHumansMaleMexiletineMiddle AgedTachycardia, VentricularTreatment Outcomeresearch article32336522open access10.1016/j.repc.2017.11.0182174-2049https://doi.org/10.1016/j.repc.2017.11.018